TGFB3 and Alzheimer disease: Macrophages were treated with IL4/TGFβ3 or IL4/TGFβ3/LN211 to mimic S1 identity loss during AD or the restorative LN211 treatment respectively, and then cocultured with Siglec-F+ eosinophil enriched BM cells.